OrphanDrug
OrphanDrug
Pharma Knowledge Base

Léri–Weill dyschondrosteosis

MeSH: C537119ORPHA: 240

Contents

  1. 1. Overview
  2. 2. Available Treatments
  3. 3. Clinical Presentation
  4. 4. Classification & Codes

Overview

human disease

Available Treatments (0)

No treatments linked yet

Clinical trials or compassionate use may be available — consult a specialist.

Clinical Presentation

Signs and symptoms associated with Léri–Weill dyschondrosteosis, sourced from HPO and Orphanet clinical annotations.

Abnormal humerus morphologyWide nasal bridgeAbnormal metaphysis morphologyBrachydactylyAbnormal carpal morphologyJoint stiffnessHypoplastic fingernailAbnormal pelvic girdle bone morphologyAbnormal morphology of the radiusAbnormal femur morphologyGenu varumTibial bowingMicromeliaHypoplasia of the radiusRadial bowingAbnormal tibia morphologyHypoplasia of the ulnaMesomeliaUlnar bowingMadelung deformityAbnormal hip bone morphologyClinodactyly of the 5th fingerDiaphyseal undertubulationDepressed nasal bridgeShort tibiaAbnormal epiphysis morphologyLimited wrist movementPatellar aplasiaDorsal subluxation of ulnaDisproportionate short-limb short statureCone-shaped epiphysisAplastic/hypoplastic toenailAbnormal morphology of ulnaExostosesAbnormal calvaria morphologyGenu valgumElbow dislocation

Classification & Codes

MeSH Code

C537119

Orphanet Code

ORPHA:240
Léri–Weill dyschondrosteosis
MeSHC537119
OrphanetORPHA:240
Treatments0 drug(s)
Symptoms on record37 signs
Statuspublished
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO